Table 3 Odds ratios (ORs) for HCV Ab seropositivity by the UACR and other potential risk factors using regression analyses.

From: Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes

Variables

Crude

Multivariate Model 1

Multivariate Model 2

OR

95% CI

P

OR

95% CI

P

OR

95% CI

P

UACR

  

< 0.001*

  

< 0.001*

  

0.015*

 < 30 mg/g

1

  

1

  

1

  

30–299 mg/g

1.741

(1.060, 2.860)

0.029

1.617

(0.979, 2.672)

0.061

1.463

(0.872, 2.456)

0.150

 ≥ 300 mg/g

3.195

(1.748, 5.840)

 < 0.001

2.989

(1.623, 5.506)

 < 0.001

2.300

(1.160, 4.562)

0.017

Age ≥ 65 years

   

1.829

(1.113, 3.008)

0.017

1.774

(1.063, 2.959)

0.028

Male

   

0.543

(0.347, 0.850)

0.007

0.554

(0.353, 0.868)

0.010

Systolic BP ≥ 140 mm Hg

      

1.434

(0.907, 2.268)

0.123

eGFR < 60 mL/min/1.73 m2

      

1.170

(0.709, 1.931)

0.540

ABI ≤ 0.9

      

0.575

(0.173, 1.915)

0.367

Use of insulin therapy

      

1.414

(0.849, 2.354)

0.183

  1. ABI ankle-brachial index, BP blood pressure, CI confidence interval, eGFR estimated glomerular filtration rate, HCV Ab hepatitis C virus antibody, OR odds ratio, UACR urinary albumin-to-creatinine ratio.
  2. Model 1: adjusted for age and sex; Model 2: adjusted for age, sex, systolic BP, eGFR, ABI, and use of insulin therapy.
  3. *P value for trend.
Back to article page